2m 2m 2m 2m 2m 2m 2m
Haemonetics (HAE)
NYSE
$104.46+$0.08 (+0.08%)
Price as of Oct 02, 2026 4:18 PM EDT- $4.7BMarket Cap
- 113.44%1-Year Change
- Medical DevicesIndustry
Haemonetics (HAE)
$104.46+$0.08 (+0.08%)
Earnings Score
Valuation | HAE | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 1 | ||
Growth | 0 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | HAE | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 35.93% | ||
12-Month Momentum | 108.87% | ||
3-Month Risk Adjusted Momentum | 186.04% | ||
12-Month Risk Adjusted Momentum | 224.00% |
True Yield
Valuation | HAE | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 0.56% | ||
Net Debt Paydown Yield | 1.66% |
Financial Health Score
Valuation | HAE | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 6 |